News
People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given ...
A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...
COPENHAGEN (Reuters) -Drugmaker Novo Nordisk said on Monday it would halt its Wegovy weight-loss drug agreement with U.S.
Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.
CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...
Prescriptions for Mounjaro jabs, to help people lose weight, will be available at GP surgeries in England from today - but ...
Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...
An experimental weight-loss medication was shown to help people lose nearly 25% of their body weight in early-stage 1a/2b trials. The drug, amycretin — developed by Novo Nordisk — works by replicating ...
A new drug called amycretin has shown it can help reduce body weight in two early-phase clinical trials. The drug, which ...
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
An article published in the journal Nature Metabolism presents an experimental drug that stimulates adipose tissue cells to ...
Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results